19 June 2013
Keywords: solasia, first, drug, trial, initiated, japan, china
Article | 23 March 2009
Tokyo, Japan-based Solasia Pharma KK, a developer of western oncology pharmaceuticals in-licensed for commercialization in Asian markets, has
initiated a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 March 2009
16 March 2009
30 March 2009
© 2013 thepharmaletter.com